Viewing Study NCT00538603


Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2026-02-24 @ 3:52 AM
Study NCT ID: NCT00538603
Status: COMPLETED
Last Update Posted: 2015-12-17
First Post: 2007-10-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
Sponsor: King Faisal Specialist Hospital & Research Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-06
Start Date Type: None
Primary Completion Date: 2013-06
Primary Completion Date Type: ACTUAL
Completion Date: 2013-06
Completion Date Type: ACTUAL
First Submit Date: 2007-10-01
First Submit QC Date: None
Study First Post Date: 2007-10-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-12-16
Last Update Post Date: 2015-12-17
Last Update Post Date Type: ESTIMATED